rs1805087 — MTR A2756G
Methionine synthase — uses B12 to convert homocysteine to methionine
Details
- Gene
- MTR
- Chromosome
- 1
- Risk allele
- G
- Protein change
- p.Asp919Gly
- Consequence
- Missense
- Inheritance
- Codominant
- Clinical
- Benign
- Evidence
- Moderate
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Methylation & DetoxMTR — The Methionine Synthase
Methionine synthase (MTR), also known as MS, catalyzes the final step that converts homocysteine back to methionine using methylcobalamin (active B12) as a cofactor and methylfolate as the methyl donor. This reaction sits at the crossroads of the methylation cycle and is essential for keeping homocysteine levels in check.
The Mechanism
The A2756G variant (rs1805087) causes an aspartic acid-to-glycine substitution 11 Aspartic acid-to-glycine substitution at position 919 of the protein (p.Asp919Gly) at position 919 of the MTR protein. The G allele produces an enzyme with altered activity that tends to favor the active (reduced) state of B12. Paradoxically, this may seem beneficial, but the altered enzyme kinetics can lead to disrupted methylation cycling under certain conditions, particularly when B12 or folate levels are suboptimal. ClinVar classifies this variant as benign given its population frequency.
The Folate Trap
MTR is at the center of what biochemists call the "methyl-folate trap." 22 When MTR is impaired, methylfolate accumulates unusably — a functional folate deficiency despite normal blood levels When MTR activity is impaired, methylfolate accumulates because it cannot donate its methyl group to homocysteine. This creates a functional folate deficiency even when total folate levels appear adequate. Understanding your MTR status helps explain why some people with "normal" folate levels still show signs of impaired methylation.
Clinical Significance
Studies have linked the G allele to altered homocysteine metabolism, though the
effects are typically modest. A meta-analysis33 meta-analysis
Zhao D et al. MTR A2756G and cancer risk, 2010 examined the variant's
association with cancer risk across multiple study types. The variant becomes more
clinically relevant when combined with MTRR variants (which affect B12 reactivation)
and MTHFR variants (which affect methylfolate production). This triad of enzymes
works as a coordinated system 44 MTR + MTRR + MTHFR form a triad: folate provides the methyl group, B12 carries it, and MTRR keeps B12 active, and weakness at multiple points compounds the effect.
Practical Implications
If you carry the G allele, ensuring generous B12 intake is important since your MTR enzyme has altered B12 handling. Active B12 forms are preferred. Combined with adequate folate (as methylfolate if you have MTHFR variants), this supports optimal homocysteine conversion and methylation cycling.
Interactions
MTR works directly with MTRR (rs1801394) — MTR performs the reaction and MTRR reactivates it. Both interact with MTHFR (rs1801133) as the provider of the methylfolate substrate.
Nutrient Interactions
Genotype Interpretations
What each possible genotype means for this variant:
Normal MTR enzyme activity
Your MTR enzyme functions normally. This enzyme uses B12 to convert homocysteine to methionine, a key step in the methylation cycle. About 65% of people share this genotype.
Altered MTR activity
You carry one variant allele, which may alter MTR activity and increase your B12 needs slightly. About 31% of people share this genotype.
Significantly altered MTR activity
You have two copies of this variant. Your MTR enzyme is less efficient, potentially leading to higher homocysteine and increased B12 requirements. About 4% of people share this genotype.
Key References
Meta-analysis of methionine synthase A2756G polymorphism and cancer risk across multiple studies
Meta-analysis of one-carbon metabolism gene variants and neural tube defect risk
MTR A2756G gene polymorphism analysis in autism patients showing altered methylation
COMT Val158Met influences morphine requirements — contextualizing MTR in B12 metabolism